Application no. and date | 15733498.8 (espacenet) (Federated) (European Patent Register), 20150625 | Patent/reg. no. and date | DK/EP 3119794, 20171011 | Publication date | 20170125 | Priority no. and date | GB 201411253, 20140625, IN 2050MU2014, 20140625, GB 201417646, 20141006 | EP pub. no. and date |
EP 3119794 20170125 | Effective date | | Applicant/owner | NuCana PLC, 77-78 Cannon Street, London EC4N 6AF, GB | Applicant ref. no. | V1712-052-DK | Inventor | GRIFFITH, Hugh, NuCana BioMed Limited 77-78 Cannon Street
London EC4N 6AF, GB, KENNOVIN, Gordon, NuCana BioMed Limited 77-78 Cannon Street
London EC4N 6AF, GB | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/7068 (2006.01) , A61K 47/16 (2006.01) , A61K 47/18 (2017.01) , A61K 47/20 (2006.01) , A61K 47/22 (2006.01) , A61K 47/26 (2006.01) , A61K 47/44 (2017.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 35/00 (2006.01) , C07H 19/10 (2006.01) | Title | FORMULERING, DER OMFATTER ET GEMCITABIN-PRODRUG | Int. application no. | GB2015051858 | Int. publication no. | WO2015198059 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|